Graham D. Reeve Sells 1,724 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH) Stock

U.S. Physical Therapy, Inc. (NYSE:USPH) COO Graham D. Reeve sold 1,724 shares of U.S. Physical Therapy stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $96.29, for a total value of $166,003.96. Following the completion of the sale, the chief operating officer now owns 7,106 shares in the company, valued at approximately $684,236.74. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.

U.S. Physical Therapy Price Performance

USPH opened at $91.87 on Thursday. The company has a current ratio of 1.78, a quick ratio of 1.88 and a debt-to-equity ratio of 0.27. The company has a market cap of $1.39 billion, a price-to-earnings ratio of 97.73, a price-to-earnings-growth ratio of 4.16 and a beta of 1.38. The stock has a fifty day simple moving average of $84.02 and a two-hundred day simple moving average of $91.26. U.S. Physical Therapy, Inc. has a 12-month low of $76.18 and a 12-month high of $113.63.

U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings data on Tuesday, August 13th. The company reported $0.73 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.82 by ($0.09). U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. The company had revenue of $167.19 million for the quarter, compared to analysts’ expectations of $163.34 million. During the same quarter in the previous year, the firm posted $0.76 EPS. The firm’s quarterly revenue was up 10.4% compared to the same quarter last year. Research analysts predict that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, December 6th. Stockholders of record on Friday, November 15th will be given a $0.44 dividend. This represents a $1.76 annualized dividend and a dividend yield of 1.92%. The ex-dividend date is Friday, November 15th. U.S. Physical Therapy’s dividend payout ratio is presently 187.23%.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on the company. StockNews.com raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Wednesday, August 21st. Barrington Research reaffirmed an “outperform” rating and set a $108.00 target price on shares of U.S. Physical Therapy in a research note on Thursday, November 7th. Finally, Bank of America reissued a “neutral” rating and issued a $90.00 price target (down from $114.00) on shares of U.S. Physical Therapy in a research note on Monday, October 7th.

Institutional Trading of U.S. Physical Therapy

Several institutional investors have recently bought and sold shares of USPH. Canada Pension Plan Investment Board bought a new position in shares of U.S. Physical Therapy in the second quarter worth approximately $28,000. Innealta Capital LLC bought a new position in U.S. Physical Therapy in the 2nd quarter valued at approximately $30,000. Quest Partners LLC boosted its stake in U.S. Physical Therapy by 2,808.3% during the 2nd quarter. Quest Partners LLC now owns 349 shares of the company’s stock valued at $32,000 after purchasing an additional 337 shares during the last quarter. Quarry LP increased its holdings in shares of U.S. Physical Therapy by 1,291.9% in the 2nd quarter. Quarry LP now owns 515 shares of the company’s stock worth $48,000 after purchasing an additional 478 shares in the last quarter. Finally, Ridgewood Investments LLC purchased a new position in shares of U.S. Physical Therapy in the second quarter worth $51,000.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.